BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 20091864)

  • 1. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
    Hoffmann M; Ihloff AS; Görögh T; Weise JB; Fazel A; Krams M; Rittgen W; Schwarz E; Kahn T
    Int J Cancer; 2010 Oct; 127(7):1595-602. PubMed ID: 20091864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?
    Hoffmann M; Tribius S; Quabius ES; Henry H; Pfannenschmidt S; Burkhardt C; Görögh T; Halec G; Hoffmann AS; Kahn T; Röcken C; Haag J; Waterboer T; Schmitt M
    Cancer Lett; 2012 Oct; 323(1):88-96. PubMed ID: 22484467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirus-associated Bowen disease.
    Murao K; Yoshioka R; Kubo Y
    J Dermatol; 2014 Oct; 41(10):878-84. PubMed ID: 25201325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival.
    Wittekindt C; Gültekin E; Weissenborn SJ; Dienes HP; Pfister HJ; Klussmann JP
    Adv Otorhinolaryngol; 2005; 62():72-80. PubMed ID: 15608419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
    Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
    Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.
    Hafkamp HC; Manni JJ; Haesevoets A; Voogd AC; Schepers M; Bot FJ; Hopman AH; Ramaekers FC; Speel EJ
    Int J Cancer; 2008 Jun; 122(12):2656-64. PubMed ID: 18360824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
    Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
    Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.
    Klussmann JP; Gültekin E; Weissenborn SJ; Wieland U; Dries V; Dienes HP; Eckel HE; Pfister HJ; Fuchs PG
    Am J Pathol; 2003 Mar; 162(3):747-53. PubMed ID: 12598309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.
    Prigge ES; Toth C; Dyckhoff G; Wagner S; Müller F; Wittekindt C; Freier K; Plinkert P; Hoffmann J; Vinokurova S; Klussmann JP; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2015 Apr; 136(7):1589-99. PubMed ID: 25104331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
    Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ
    Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma.
    Mellin Dahlstrand H; Lindquist D; Björnestål L; Ohlsson A; Dalianis T; Munck-Wikland E; Elmberger G
    Anticancer Res; 2005; 25(6C):4375-83. PubMed ID: 16334111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
    Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
    Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.
    Steinestel J; Al Ghazal A; Arndt A; Schnoeller TJ; Schrader AJ; Moeller P; Steinestel K
    BMC Cancer; 2015 Apr; 15():220. PubMed ID: 25885064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.